Cary Street Partners Investment Advisory’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,900
| Closed | -$328K | – | 727 |
|
|
2023
Q4 | $328K | Sell |
13,900
-6,100
| -31% | -$144K | 0.02% | 516 |
|
|
2023
Q3 | $298K | Sell |
20,000
-10,000
| -33% | -$149K | 0.02% | 478 |
|
|
2023
Q2 | $329K | Hold |
30,000
| – | – | 0.02% | 421 |
|
|
2023
Q1 | $262K | Sell |
30,000
-10,000
| -25% | -$87.2K | 0.02% | 424 |
|
|
2022
Q4 | $251K | Hold |
40,000
| – | – | 0.02% | 430 |
|
|
2022
Q3 | $140K | Hold |
40,000
| – | – | 0.01% | 474 |
|
|
2022
Q2 | $118K | Buy |
40,000
+10,000
| +33% | +$29.5K | 0.01% | 489 |
|
|
2022
Q1 | $93K | Buy |
+30,000
| New | +$93K | 0.03% | 271 |
|